The discovery of GSK221149A: a potent and selective oxytocin antagonist.

The discovery of GSK221149A: a potent and selective oxytocin antagonist.

Item
http://www.wikidata.org/entity/Q34716885
Rational and combinatorial tailoring of bioactive cyclic dipeptidesEnabling large-scale design, synthesis and validation of small molecule protein-protein antagonistsConcise Two-Step Solution Phase Syntheses of four novel Dihydroquinazoline scaffolds.The design of orally bioavailable 2, 5-diketopiperazine oxytocin antagonists: from concept to clinical candidate for premature labor.Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics.Treatment of spontaneous preterm labour with retosiban: a phase 2 proof-of-concept studyFacile, novel two-step syntheses of benzimidazoles, bis-benzimidazoles, and bis-benzimidazole-dihydroquinoxalines.Chemistry and biology of multicomponent reactions.A Phase 1 Randomized, Placebo-Controlled Study Assessing the Pharmacokinetics, Safety, and Tolerability of Retosiban in Healthy, Nonpregnant Japanese Subjects.Treatment of spontaneous preterm labour with retosiban: a phase II pilot dose-ranging studyEfficient assembly of iminodicarboxamides by a "truly" four-component reaction.Polycyclic compounds by Ugi-Pictet-Spengler sequence.Various cyclization scaffolds by a truly Ugi 4-CR.Synthesis of α-amino-1,3-dicarbonyl compounds via Ugi flow chemistry reaction: access to functionalized 1,2,3-triazoles.
P2860

The discovery of GSK221149A: a potent and selective oxytocin antagonist.

Item
http://www.wikidata.org/entity/Q34716885
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The discovery of GSK221149A: a potent and selective oxytocin antagonist.
@ast
The discovery of GSK221149A: a potent and selective oxytocin antagonist.
@en
The discovery of GSK221149A: a potent and selective oxytocin antagonist.
@nl
type
label
The discovery of GSK221149A: a potent and selective oxytocin antagonist.
@ast
The discovery of GSK221149A: a potent and selective oxytocin antagonist.
@en
The discovery of GSK221149A: a potent and selective oxytocin antagonist.
@nl
prefLabel
The discovery of GSK221149A: a potent and selective oxytocin antagonist.
@ast
The discovery of GSK221149A: a potent and selective oxytocin antagonist.
@en
The discovery of GSK221149A: a potent and selective oxytocin antagonist.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
The discovery of GSK221149A: a potent and selective oxytocin antagonist.
@en
P2093
P304
P31
P356
10.1016/J.BMCL.2007.11.008
P407
P433
P478
P577
P5875
P698
P921